Abstract Background: Despite the fact that Light's criteria remain the gold standard approach in differentiating exudates from transudates, several fluid markers have been introduced for establishing the cause of pleural effusion to differentiate types of pleural exudate.
Introduction
A pleural effusion refers to an abnormal accumulation of fluid in the pleural cavity, it is often a result of local pleuropulmonary diseases but can also complicate many systemic pathologies. Pleural effusion develops when the rate of pleural fluid formation exceeds that of its drainage. Establishing the underlying cause of pleural effusion is often challenging because a wide range of local and systemic diseases can lead to pleural effusion formation. Pleural fluid samples should be analyzed to determine whether it is a transudate or exudate [10] .
This distinction determines not only the differential diagnosis and thus the following therapeutic intervention, but also the underlying pathophysiologic mechanisms which lead to the aggregation of fluid in the pleural cavity. Indeed, an exudative pleural effusion occurs when the permeability of the mesothelial capillary barrier to albumin and other macromolecules is elevated. In contrast, the presence of a transudate indicates that the systemic or pulmonary pressures influencing the formation or reabsorption of pleural fluid are altered [6] .
Despite the fact that Light's criteria remain the gold standard approach in differentiating exudates from transudates, several fluid markers have been introduced for diagnostic analysis. The measurement of pleural fluid interleukin-6, TNFa, CRP, interferon-gamma, interleukin-1 and immunological cytokines has been shown to be beneficial to the diagnosis of exudative pleural effusion [17] .
Cytokines are proteins with relatively low molecular weight that are secreted by cells in response to a variety of different stimuli and act as key mediators of the host response to various infections, inflammatory, and immunologic challenges. Cytokines are thought to exert their effects by binding to specific receptors on the surface of the cell, although cytokines may in some instances have direct membrane effects [14] .
Tumor necrosis factor alpha (TNF-a), isolated 30 years ago, is a multifunctional cytokine playing a key role in apoptosis and cell survival as well as in inflammation and immunity. Although named for its antitumor properties, TNF-a has been implicated in a wide spectrum of other diseases [23] .
Tumor necrosis factor-a is a small polypeptide with pleiotropic effects on biological and immunological processes. It is a key cytokine in inflammatory reactions, and high levels of this cytokine in pleural fluid have been detected in several diseases that cause pleural effusion [13] .
Patients and methods
This study was conducted on 45 patients (28-males and 17 females) with pleural effusions of different etiologies, at Benha University Hospital and Elmehlla chest hospital during the period from December 2012 till December 2013 after approval of the study protocol by the Local Ethics Committee and obtaining fully written informed patients' consent. The patients were classified according to their final diagnosis into four groups: Group I: 10 cases (6 males and 4 females) with tuberculous pleural effusions. Group II: 15 cases (8 males and 7 females) with malignant pleural effusions. Group III: 10 cases (7 males and 3 females) with para-pneumonic effusion. Group IV: 10 cases (7 males and 3 females) with transudative pleural effusions of congestive heart failure included as a control group (Table 2) . 
Statistical analysis
Data collected were analyzed using SPSS version 20 software. Chi square test (v2), Student's ''t" test and ANOVA were used as tests of significance. ROC curve was used to detect cutoff values of TNFa with optimum sensitivity and specificity. Stepwise multiple regression analysis was done to detect the significant predictors of TNFa.
Results
The mean age (in years) of Group I was 50.3 + 15.1, Group II was 67.6 + 10.4, Group III was 46.1 + 11.9 and Group IV was 59.1 + 10.7 years with male predominance (Table 1) .
The mean values of pleural fluid and serum TNF-a levels were as follows: Group (I) (258.3 + 70.6 and 35.5 + 7.43 pg/ ml), respectively, in Group (II) (50.8 + 18.1 and 26.8 + 6.31 pg/ml). In Group (III) (88.1 + 35.4 and 26.9 + 10.1 pg/ml), respectively. While in Group (IV) control, the mean levels were (21.4 + 8.9 and 18.8 + 7.15 pg/ml), respectively, (Table 4 ). There was a statistically significant difference in the serum and the pleural fluid mean values of TNF-a among the four groups (P = 0.001) with a statistically significant difference between tuberculous Group (I) which showed the statistically significant highest mean and the three other groups in which transudative group showed the statistically significant lowest mean (Table 3 and Figs. 1-3 ).
There was a significant difference in the mean levels of serum and PL TNF-a in exudative effusions (mean was 29.1 + 8.55 and 120.7 + 99.1 pg/ml, versus transudative effusions (mean was 18.8 + 7.15 and 21.4 + 8.8 pg/ml)), respectively, P 6 0.05 and also the ratio (Table 4 and Fig. 4 ).
There was a significant increase in pleural fluid and ratio of TNF-a levels in the non malignant group versus the malignant group. (P < 0.003) and no statistically significant difference between the mean values of serum TNF-a of the two groups (P > 0.05) ( Table 5 and Fig. 5 ).
The efficacy of pleural fluid TNF-a measurement in distinguishing between exudative and transudative effusions at a cutoff value of >20 pg/ml was determined by standard ROC analysis. The sensitivity of TNF-a in differentiation between exudative and transudative pleural effusions based on this optimal cutoff level was 91.2%. The specificity of exudative pleural effusion was 84.2% (Table 6 and Fig. 6 ).
The efficacy of pleural fluid TNF-a measurement in distinguishing between non malignant and malignant effusions at a cutoff value of >78 pg/ml was determined by standard ROC analysis. The sensitivity and specificity of TNF-a in differentiation between non malignant and malignant pleural effusions based on this optimal cutoff level were 91.7% and 91.4%, respectively (Table 7 and Fig. 7) .
The sensitivity and specificity of pleural TNF-a level in differentiating between parapneumonic and malignant pleural effusions at a cutoff point of 37.2 pg/ml were 91.6% and 86.3%, respectively. And between TB and malignant pleural effusions at a cutoff point of 78 pg/ml were 86.2% and 79.3%, respectively (Table 8 and Figs. 8 and 9 ).
Discussion
The diagnosis and management of pleural effusion remain a clinical challenge. Although a variety of simple laboratory tests are in use, a number of cases remain undiagnosed or the ''diagnosis" is based on clinical evidence alone. This is especially true regarding the differentiation of exudates of various causes [25] .
A definitive diagnosis, as is provided by the finding of malignant cells or specific organism in the pleural fluid can be established in approximately 25% of cases. However, a presumptive diagnosis, based on the prethoracentesis clinical impression and pleural effusion analysis, clinical decisionmaking information can be gained in over 90% of patients [5] . The potential utility of many biochemical and immunological markers has recently been the subject of research due to the high costs and the morbidity and mortality risks associated with the invasive procedures [20] .
The aim of this work was to assess the role of tumor necrosis factor-a in differentiation between malignant and non malignant pleural effusions. As shown in Table 1 the incidence of tuberculous pleural effusion in this study was found to be in the fifth decade and more, this in comparison to the findings of Hopwell [7] who found that the incidence of pleural tuberculosis increases with age between 5 and 45 years. However, more recent studies reported an older mean age with 10-15% of the patients being over the age of 70 years [11] .
The present study showed the incidence of para-pneumonic effusion shown in Table 1 was found to be more common in patients in their 4th decade and more. Light [12] stated that pleural infection affects patients of all ages but is more common in the elderly and childhood.
The incidence of tuberculous pleural effusion in the present study was found to be more in males than in females; this is in agreement with the finding of Hopewell [7] who found that tuberculous pleural effusion is more common in males. However, Kritski and Fiuza De Melo [9] , stated that there was no difference in the gender distribution in cases of tuberculous pleural effusion.
The incidence of para-pneumonic effusion was found to be more in males than in females this is in agreement with the findings of Ortqvist et al. [15] who stated that the incidence of para-pneumonic effusion in males is twice that of females. Table 3 and Figs. 1-3 show that TNF-a was increased in pleural fluid of both malignant and inflammatory exudates, compared to transudates. The highest mean values of TNFa, were found in tuberculous pleural effusion followed by parapneumonic pleural effusion then malignant effusion while that of transudative effusion came last with the lowest mean values. These findings were in accordance with that of [8] who found that pleural fluid TNF-a levels were higher in tuberculous compared to parapneumonic and malignant effusions. This may be useful for the differentiation between tuberculous and malignant effusions.
In Table 4 and Fig. 4 , TNF-a was found to be expressed in higher levels in exudative pleural effusions due to different causes than those due to transudative pleural effusions in which they were expressed in lower levels, this is in agreement with Rezaeetalab et al. [19] who stated the diagnostic value of TNF-a in the pleural fluid for the discrimination between exudates and transudates. Exudates presented a higher TNF-a level than transudates, which is synthesized by various activated phagocytic and non phagocytic cells, and play a key role in inflammatory processes. It is produced during a wide variety of infections, malignancy and other inflammatory conditions.
In Table 5 and Fig. 5 , TNF-a was found to have a significant increase in the non malignant group versus the malignant group, this is in agreement with Sen [20] who studied the predictive value of TNFa and other cytokines in the diagnosis of malignant pleural effusions and found that TNFa levels were higher in the benign group.
The results of the study clearly showed that the mean levels of TNFa were significantly greater in the pleural fluid of patients compared with serum. This was explained by Yenisey et al. [25] who stated this is probably due to local production of the cytokine by inflammatory cells that have accumulated in the pleural cavity, although stimulated mesothelial cells may also contribute to the higher cytokine levels in pleural exudates.
Smith et al. [21] had explained the significantly higher levels of TNF-a in tuberculous effusions may be a part of a complex immune response in the pleural space, as TNF-a has both protective and deleterious roles in tuberculosis. Mycobacterial products are potent stimuli for TNF-a production by monocytes, providing a plausible explanation for the high levels of TNF-a in tuberculous effusions this also is in accordance with [2] and with [1] .
The usefulness of pleural fluid TNF-a in the diagnosis and outcome prediction of pleural TB stated by Wonga et al. [24] who also found that the percentage change of this cytokine after 2 weeks of treatment also helps to predict the outcome of pleural TB. TNF-a was the single cytokine that significantly increased in the pleural fluid of the TB patients with pulmonary involvement as stated by Antonangelo et al. [3] who found that TNF-a was significantly increased in the pleuropulmonary tuberculosis patients. This finding could suggest a more pronounced inflammatory response because of the concomitance of the anatomic sites involved.
TNF-a is expressed in higher values in parapneumonic effusion than those of malignant and transudative pleural effusions but it is expressed in lower levels than those of tuberculous pleural effusions. These results were also in agreement with the findings of Daniil et al. [4] . This is also in agreement with Porcel et al. [16] who suggested that pleural TNF-a could be a biochemical marker of inflammation in patients with PPE. Additionally, elevated levels of pleural TNF-a identified the subgroup of patients with no purulent-appearing PPE who required invasive management with tube thoracostomy more reliably than traditional fluid chemistries and could be considered as an indicator of poor prognosis in patients with PPE.
High level of TNF-a in malignant pleural effusion stated by Stathopoulos et al. [22] who also identified tumor-derived TNF-a has an important effect of MPE formation and progression. In addition it provided preclinical evidence for the efficacy of TNF-a blockade against MPE.
On the contrary, Ragab et al. [18] found that TNFa had a very limited diagnostic value as it shows a slight elevation among newly diagnosed lung cancer patients. But they considered its role in predicting the stage and monitoring lung cancer, where TNF-a elevation was proportional to the deterioration of the disease grade and cases with metastasis showed higher TNF-a than those having no metastasis. TNF-a could be of Figure 4 Mean levels of TNF-a in pleural fluid, serum and PF/S ratio in exudative and transudative effusions. great help in the early detection of metastasis in lung cancer, and could be a valuable factor in following high-risk lung cancer patients. Daniil et al. [4] found that TNF-a concentration levels were more increased in TPE and stated that combinations of TNF-a and biological markers as ADA, CRP, CEA, IFN-c, IL-6 and VEGF concentrations are useful in the discrimination of exudative pleural effusions.
In the present study (Table 6 and Fig. 6 ) a cutoff point of 20 pg/ml pleural fluid TNF-a can be used to differentiate exudative pleural effusion from transudative pleural effusion with sensitivity 91.2%, specificity 84.2%, PPV 92.5%, NPV 85.3%, respectively. Rezaeetalab et al. [19] found that TNFa levels >12.9 ng/dl are definitely valuable in differentiating exudative from transudative pleural effusion. This difference in values may be due to the sample size. Figure 6 ROC curve for the performance of TNF-a in the diagnosis of exudative effusion. Regarding (Table 7 and Fig. 7 ), a cutoff point of 78 pg/ml pleural fluid TNF-a can be used to differentiate malignant pleural effusion from non malignant pleural effusion with sensitivity 91.7%, specificity 91.4%, PPV 86.6%, NPV 92.5%, respectively. This could contribute to the solution to major problem doctors face every day to differentiate between malignant and infectious effusions, due to their different outcome and management.
In Table 8 and Figs. 8 and 9 a cutoff point of 37.2 pg/ml pleural fluid TNF-a can be used to differentiate parapneumonic pleural effusion from malignant pleural effusion with sensitivity 91.6%, specificity 86.3%, PPV 84.6%, NPV 92.5%, respectively and a cutoff point of 78 pg/ml pleural fluid TNF-a can be used to differentiate tuberculous pleural effusion from malignant pleural effusion with sensitivity 86.2%, specificity 79.3%, PPV 88.3%, NPV 81.7%, respectively.
These results agree with those of Kiropoulos et al. [8] who reported that TNF-a presented acceptable performance as a marker for the differentiation between tuberculous and malignant effusions, presenting 96% sensitivity, 93.6% specificity for a cut-off point of 88.1 pg/ml of the ROC analysis curve. And a cut-off point of 43.9 pg/ml of the ROC analysis curve for the differentiation between parapneumonic and malignant effusions with 68.7% sensitivity, 62.5% specificity.
Conclusion
TNF-a was found in high concentrations in the pleural fluid of exudative nature compared to transudative pleural effusion being higher in tuberculous effusion compared with other types of exudative effusion. TNF-a in the serum and pleural fluid could be a useful confirmation differential diagnosis of tuberculous and malignant effusions. 
